Good Life Meds vs Noom
Good Life Meds and Noom both sell semaglutide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Good Life Meds
Best for: seeing what it charges before you answer any medical questions
Visit Good Life Meds →
If you are choosing between Good Life Meds and Noom, price alone will not settle it. Both prescribe semaglutide, so moving from one to the other would not change your drug. Noom leads our six-part score, 6.7 to 6.6.
Good Life Meds vs Noom price
Good Life Meds and Noom start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $199 a month.
Medications and formats
Both sell semaglutide; only Noom lists tirzepatide.
On format, Good Life Meds prices compounded injections, while Noom prices brand-name pens and compounded injections.
If you want the FDA-approved brand rather than a compounded version, Noom is the only one of the two with a brand-name price.
Where each one treats patients
Neither Good Life Meds nor Noom publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Good Life Meds
Noom
What each price covers
Both prices cover the clinician visit.
Good Life Meds' price also covers the medication itself and shipping, which Noom does not claim.
Noom's price also covers coaching, which Good Life Meds does not claim.
Good Life Meds is silent on lab work and coaching.
Noom is silent on the medication itself, shipping and lab work.
That matters most for the drug: unless Noom confirms otherwise, budget for medication on top of its listed price.
Good Life Meds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, Noom scores 6.7 and Good Life Meds 6.6 out of 10.
Good Life Meds is stronger on support (7.0 vs 4.0).
Noom is stronger on effectiveness (10.0 vs 8.5).
Value, user experience, trust & safety and accessibility are within half a point.
Good Life Meds
6.6/10
Noom
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Good Life Meds nor Noom has an FDA warning letter on record with us.
Features & Coverage
| Feature | Good Life Meds | Noom |
|---|---|---|
| Starting Price | $199/mo | $199/mo |
| Features | 2 features | 2 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Good Life Meds
Good Life Meds is a telehealth weight loss clinic that prescribes GLP-1 medications.
Read our full Good Life Meds review →About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →Pros & Cons
Good Life Meds
What we like
- Semaglutide costs $199 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Good Life Meds
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Noom
What we like
- Semaglutide costs $199 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Noom wins this one, 6.7 to 6.6, above all for coaching bundled into the price rather than sold separately. Good Life Meds fits better if seeing what it charges before you answer any medical questions is your priority.
Choose Good Life Meds if…
You want seeing what it charges before you answer any medical questions and an opening price near $199 a month.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →Good Life Meds vs Noom: FAQ
Close alternatives to Good Life Meds and Noom
- Good Life Meds vs Dollar Dad Club
- Good Life Meds vs Alegro Health
- Good Life Meds vs Chronos Body Health & Wellness
- Good Life Meds vs Clume Health
- Noom vs Hims
- Noom vs Hers
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.